头颈部鳞状细胞癌免疫微环境及其作用机制的最新研究进展及展望

张少秋; 燕丽; 李瑞辰; 赵阳; 王孝深; 杨旭光; 朱奕

doi:10.19401/j.cnki.1007-3639.2023.06.011

您当前的位置：

首页 >

文章列表页 >

头颈部鳞状细胞癌免疫微环境及其作用机制的最新研究进展及展望

综述 | 更新时间：2025-12-31

- 头颈部鳞状细胞癌免疫微环境及其作用机制的最新研究进展及展望
- Recent advances and prospect in immune microenvironment and its mechanisms of function in head and neck squamous cell carcinoma
- 中国癌症杂志 2023年33卷第6期页码：629-636
- 作者机构：
  
  1. 复旦大学附属眼耳鼻喉科医院放疗科，上海 201112
  2. 上海中医药大学附属龙华医院临床研究中心，上海200032
- 作者简介：
  
  [ "张少秋（ORCID: 0009-0001-6385-2644），硕士研究生。" ]
  朱奕（ORCID：0000-0002-2222-0106），博士，副主任医师。
- 基金信息：
- DOI：10.19401/j.cnki.1007-3639.2023.06.011
  中图分类号： R739.91
- 收稿：2023-01-02，
  
  修回：2023-05-09，
  
  纸质出版：2023-06-30
- 稿件说明：
移动端阅览
张少秋, 燕丽, 李瑞辰, 等. 头颈部鳞状细胞癌免疫微环境及其作用机制的最新研究进展及展望[J]. 中国癌症杂志, 2023,33(6):629-636.

Shaoqiu ZHANG, Li YAN, Ruichen LI, et al. Recent advances and prospect in immune microenvironment and its mechanisms of function in head and neck squamous cell carcinoma[J]. China Oncology, 2023, 33(6): 629-636.
张少秋, 燕丽, 李瑞辰, 等. 头颈部鳞状细胞癌免疫微环境及其作用机制的最新研究进展及展望[J]. 中国癌症杂志, 2023,33(6):629-636. DOI： 10.19401/j.cnki.1007-3639.2023.06.011.

Shaoqiu ZHANG, Li YAN, Ruichen LI, et al. Recent advances and prospect in immune microenvironment and its mechanisms of function in head and neck squamous cell carcinoma[J]. China Oncology, 2023, 33(6): 629-636. DOI： 10.19401/j.cnki.1007-3639.2023.06.011.

摘要

头颈部恶性肿瘤（head and neck cancer，HNC）作为一类常见的恶性肿瘤，至今仍有较高的发病率和死亡率。在HNC中，头颈部鳞状细胞癌（head and neck squamous-cell carcinoma，HNSCC）是最常见的病理学类型。肿瘤微环境（tumor microenvironment，TME）是指肿瘤细胞周围的成分，主要包括免疫细胞、基质细胞、细胞外基质（extracellular matrix，ECM）、血管和淋巴管及其驱动分子。一些针对TME的肿瘤治疗策略已在临床上广泛应用，并产生了显著的治疗效果。更深层次地探索TME中各组分之间的相互作用机制具有重要意义。本文综述了HNSCC的TME中细胞毒性T淋巴细胞（cytotoxicity T lymphocyte，CTL）、CD4

T 淋巴细胞、调节性T细胞（regulatory T cell，Treg）、髓样来源抑制细胞（marrow-derived myeloid cell，MDSC）、自然杀伤（natural killer，NK）细胞、肿瘤相关巨噬细胞（tumor-associated macrophage，TAM）的最新研究进展。本文中总结的研究主要聚焦于如何恢复抗肿瘤细胞活性，以及如何消除Treg等免疫抑制细胞的免疫抑制作用，旨在为研究更有效的HNSCC治疗方法提供新思路。

Abstract

Head and neck cancer (HNC) remains a significant cause of morbidity and mortality. The most prevalent pathology among HNC is head and neck squamous cell carcinoma (HNSCC). The tumor microenvironment (TME) encompasses the components surrounding tumor cells

including immune cells

stromal cells

extracellular matrix (ECM)

blood and lymph vessels. Strategies targeting the TME have yielded significant outcomes. Thus

further exploration of the interactions between TME components is crucial. This review discussed recent advances in cytotoxic T lymphocytes (CTL)

CD4

T lymphocytes

regulatory T cells (Treg)

myeloid-derived suppressor cells (MDSC)

natural killer (NK) cells and tumor-associated macrophages (TAM) in HNSCC TME. The article summarized herein p

rimarily focused on restoring the activity of anti-tumor cells and eliminating the immunosuppressive effects of Treg and so on

to provide new insights for more effective HNSCC therapy.

关键词

Keywords

references

GUPTA B , JOHNSON N W , KUMAR N . Global epidemiology of head and neck cancers: a continuing challenge [J ] . Oncology , 2016 , 91 ( 1 ): 13 - 23 . DOI: 10.1159/000446117 http://doi.org/10.1159/000446117

HO A S , KIM S , TIGHIOUART M , et al. Metastatic lymph node burden and survival in oral cavity cancer [J ] . J Clin Oncol , 2017 , 35 ( 31 ): 3601 - 3609 . DOI: 10.1200/JCO.2016.71.1176 http://doi.org/10.1200/JCO.2016.71.1176

FAN S , TANG Q L , LIN Y J , et al. A review of clinical and histological parameters associated with contralateral neck metastases in oral squamous cell carcinoma [J ] . Int J Oral Sci , 2011 , 3 ( 4 ): 180 - 191 . DOI: 10.4248/IJOS11068 http://doi.org/10.4248/IJOS11068

RETTIG E M , D'SOUZA G . Epidemiology of head and neck cancer [J ] . Surg Oncol Clin N Am , 2015 , 24 ( 3 ): 379 - 396 . DOI: 10.1016/j.soc.2015.03.001 http://doi.org/10.1016/j.soc.2015.03.001

COHEN N , FEDEWA S , CHEN A Y . Epidemiology and demographics of the head and neck cancer population [J ] . Oral Maxillofac Surg Clin North Am , 2018 , 30 ( 4 ): 381 - 395 . DOI: 10.1016/j.coms.2018.06.001 http://doi.org/10.1016/j.coms.2018.06.001 https://linkinghub.elsevier.com/retrieve/pii/S1042369918300530 https://linkinghub.elsevier.com/retrieve/pii/S1042369918300530

SACCO A G , COHEN E E . Current treatment options for recurrent or metastatic head and neck squamous cell carcinoma [J ] . J Clin Oncol , 2015 , 33 ( 29 ): 3305 - 3313 . DOI: 10.1200/JCO.2015.62.0963 http://doi.org/10.1200/JCO.2015.62.0963

HANAHAN D , COUSSENS L M . Accessories to the crime: functions of cells recruited to the tumor microenvironment [J ] . Cancer Cell , 2012 , 21 ( 3 ): 309 - 322 . DOI: 10.1016/j.ccr.2012.02.022 http://doi.org/10.1016/j.ccr.2012.02.022

JOYCE J A , FEARON D T . T cell exclusion, immune privilege, and the tumor microenvironment [J ] . Science , 2015 , 348 ( 6230 ): 74 - 80 . DOI: 10.1126/science.aaa6204 http://doi.org/10.1126/science.aaa6204

TADDEI M L , GIANNONI E , COMITO G , et al. Microenvironment and tumor cell plasticity: an easy way out [J ] . Cancer Lett , 2013 , 341 ( 1 ): 80 - 96 . DOI: 10.1016/j.canlet.2013.01.042 http://doi.org/10.1016/j.canlet.2013.01.042

PIETRAS K , OSTMAN A . Hallmarks of cancer: interactions with the tumor stroma [J ] . Exp Cell Res , 2010 , 316 ( 8 ): 1324 - 1331 . DOI: 10.1016/j.yexcr.2010.02.045 http://doi.org/10.1016/j.yexcr.2010.02.045

MEI Z , HUANG J W , QIAO B , et al. Immune checkpoint pathways in immunotherapy for head and neck squamous cell carcinoma [J ] . Int J Oral Sci , 2020 , 12 ( 1 ): 16 . DOI: 10.1038/s41368-020-0084-8 http://doi.org/10.1038/s41368-020-0084-8

YANG B , LIU T J , QU Y , et al. Progresses and perspectives of anti-PD-1/PD-L1 antibody therapy in head and neck cancers [J ] . Front Oncol , 2018 , 8 : 563 . DOI: 10.3389/fonc.2018.00563 http://doi.org/10.3389/fonc.2018.00563

CARLISLE J W , STEUER C E , OWONIKOKO T K , et al. An update on the immune landscape in lung and head and neck cancers [J ] . CA Cancer J Clin , 2020 , 70 ( 6 ): 505 - 517 . DOI: 10.3322/caac.v70.6 http://doi.org/10.3322/caac.v70.6 https://onlinelibrary.wiley.com/toc/15424863/70/6 https://onlinelibrary.wiley.com/toc/15424863/70/6

PAMER E , CRESSWELL P . Mechanisms of MHC classⅠ: restricted antigen processing [J ] . Annu Rev Immunol , 1998 , 16 : 323 - 358 . DOI: 10.1146/immunol.1998.16.issue-1 http://doi.org/10.1146/immunol.1998.16.issue-1 https://www.annualreviews.org/toc/immunol/16/1 https://www.annualreviews.org/toc/immunol/16/1

VAN DOMSELAAR R , QUADIR R , et al. VAN DER MADE A M, All human granzymes target hnRNP K that is essential for tumor cell viability [J ] . J Biol Chem , 2012 , 287 ( 27 ): 22854 - 22864 . DOI: 10.1074/jbc.M112.365692 http://doi.org/10.1074/jbc.M112.365692

VAN DOMSELAAR R , DE POOT S A , REMMERSWAAL E B , et al. Granzyme M targets host cell hnRNP K that is essential for human cytomegalovirus replication [J ] . Cell Death Differ , 2013 , 20 ( 3 ): 419 - 429 . DOI: 10.1038/cdd.2012.132 http://doi.org/10.1038/cdd.2012.132

MANDAL R , ŞENBABAOĞLU Y , DESRICHARD A , et al. The head and neck cancer immune landscape and its immunotherapeutic implications [J ] . JCI Insight , 2016 , 1 ( 17 ): e89829 .

LIU L H , LIM M A , JUNG S N , et al. The effect of Curcumin on multi-level immune checkpoint blockade and T cell dysfunction in head and neck cancer [J ] . Phytomedicine , 2021 , 92 : 153758 . DOI: 10.1016/j.phymed.2021.153758 http://doi.org/10.1016/j.phymed.2021.153758 https://linkinghub.elsevier.com/retrieve/pii/S0944711321003019 https://linkinghub.elsevier.com/retrieve/pii/S0944711321003019

WANG H C , CHAN L P , CHO S F . Targeting the immune microenvironment in the treatment of head and neck squamous cell carcinoma [J ] . Front Oncol , 2019 , 9 : 1084 . DOI: 10.3389/fonc.2019.01084 http://doi.org/10.3389/fonc.2019.01084 https://www.frontiersin.org/article/10.3389/fonc.2019.01084/full https://www.frontiersin.org/article/10.3389/fonc.2019.01084/full

MONTLER R , BELL R B , THALHOFER C , et al. OX40, PD-1 and CTLA-4 are selectively expressed on tumor-infiltrating T cells in head and neck cancer [J ] . Clin Transl Immunol , 2016 , 5 ( 4 ): e70 . DOI: 10.1038/cti.2016.16 http://doi.org/10.1038/cti.2016.16 http://doi.wiley.com/10.1038/cti.2016.16 http://doi.wiley.com/10.1038/cti.2016.16

MAZZONI A , CAPONE M , RAMAZZOTTI M , et al. IL4I1 is expressed by head-neck cancer-derived mesenchymal stromal cells and contributes to suppress T cell proliferation [J ] . J Clin Med , 2021 , 10 ( 10 ): 2111 . DOI: 10.3390/jcm10102111 http://doi.org/10.3390/jcm10102111 https://www.mdpi.com/2077-0383/10/10/2111 https://www.mdpi.com/2077-0383/10/10/2111

LI H Z , XIAO Y , LI Q , et al. The allergy mediator histamine confers resistance to immunotherapy in cancer patients via activation of the macrophage histamine receptor H1 [J ] . Cancer Cell , 2022 , 40 ( 1 ): 36 - 52 .e9. DOI: 10.1016/j.ccell.2021.11.002 http://doi.org/10.1016/j.ccell.2021.11.002 https://linkinghub.elsevier.com/retrieve/pii/S1535610821006024 https://linkinghub.elsevier.com/retrieve/pii/S1535610821006024

LI J Y , ZHAO Y , GONG S , et al. TRIM21 inhibits irradiation-induced mitochondrial DNA release and impairs antitumour immunity in nasopharyngeal carcinoma tumour models [J ] . Nat Commun , 2023 , 14 ( 1 ): 865 . DOI: 10.1038/s41467-023-36523-y http://doi.org/10.1038/s41467-023-36523-y

HIRAHARA K , NAKAYAMA T . CD4 + T-cell subsets in inflammatory diseases: beyond the Th1/Th2 paradigm [J ] . Int Immunol , 2016 , 28 ( 4 ): 163 - 171 . DOI: 10.1093/intimm/dxw006 http://doi.org/10.1093/intimm/dxw006 https://academic.oup.com/intimm/article/28/4/163/2614136 https://academic.oup.com/intimm/article/28/4/163/2614136

LAIDLAW B J , CRAFT J E , KAECH S M . The multifaceted role of CD4 + T cells in CD8 + T cell memory [J ] . Nat Rev Immunol , 2016 , 16 ( 2 ): 102 - 111 . DOI: 10.1038/nri.2015.10 http://doi.org/10.1038/nri.2015.10

SAKAGUCHI S , YAMAGUCHI T , NOMURA T , et al. Regulatory T cells and immune tolerance [J ] . Cell , 2008 , 133 ( 5 ): 775 - 787 . DOI: 10.1016/j.cell.2008.05.009 http://doi.org/10.1016/j.cell.2008.05.009

DUHEN T , GOUGH M J , LEIDNER R S , et al. Development and therapeutic manipulation of the head and neck cancer tumor environment to improve clinical outcomes [J ] . Front Oral Health , 2022 , 3 : 902160 . DOI: 10.3389/froh.2022.902160 http://doi.org/10.3389/froh.2022.902160 https://www.frontiersin.org/articles/10.3389/froh.2022.902160/full https://www.frontiersin.org/articles/10.3389/froh.2022.902160/full

DUHEN R , FESNEAU O , SAMSON K A , et al. PD-1 and ICOS coexpression identifies tumor-reactive CD4 + T cells in human solid tumors [J ] . J Clin Invest , 2022 , 132 ( 12 ): e156821 . DOI: 10.1172/JCI156821 http://doi.org/10.1172/JCI156821 http://www.jci.org/articles/view/156821 http://www.jci.org/articles/view/156821

KATABATHULA R , JOSEPH P , SINGH S , et al. Multi-scale pan-cancer integrative analyses identify the STAT3-VSIR axis as a key immunosuppressive mechanism in head and neck cancer [J ] . Clin Cancer Res , 2022 , 28 ( 5 ): 984 - 992 . DOI: 10.1158/1078-0432.CCR-21-1978 http://doi.org/10.1158/1078-0432.CCR-21-1978 https://aacrjournals.org/clincancerres/article/28/5/984/681682/Multi-scale-Pan-cancer-Integrative-Analyses https://aacrjournals.org/clincancerres/article/28/5/984/681682/Multi-scale-Pan-cancer-Integrative-Analyses

HEATH B R , GONG W , TANER H F , et al. Saturated fatty acids dampen the immunogenicity of cancer by suppressing STING [J ] . Cell Rep , 2023 , 42 ( 4 ): 112303 . DOI: 10.1016/j.celrep.2023.112303 http://doi.org/10.1016/j.celrep.2023.112303 https://linkinghub.elsevier.com/retrieve/pii/S2211124723003145 https://linkinghub.elsevier.com/retrieve/pii/S2211124723003145

WALKER L S . Treg and CTLA-4: two intertwining pathways to immune tolerance [J ] . J Autoimmun , 2013 , 45 : 49 - 57 . DOI: 10.1016/j.jaut.2013.06.006 http://doi.org/10.1016/j.jaut.2013.06.006

OU D , ADAM J , GARBERIS I , et al. Clinical relevance of tumor infiltrating lymphocytes, PD-L1 expression and correlation with HPV/p16 in head and neck cancer treated with bio- or chemo-radiotherapy [J ] . Oncoimmunology , 2017 , 6 ( 9 ): e1341030 . DOI: 10.1080/2162402X.2017.1341030 http://doi.org/10.1080/2162402X.2017.1341030 https://www.tandfonline.com/doi/full/10.1080/2162402X.2017.1341030 https://www.tandfonline.com/doi/full/10.1080/2162402X.2017.1341030

JIE H B , GILDENER-LEAPMAN N , LI J , et al. Intratumoral regulatory T cells upregulate immunosuppressive molecules in head and neck cancer patients [J ] . Br J Cancer , 2013 , 109 ( 10 ): 2629 - 2635 . DOI: 10.1038/bjc.2013.645 http://doi.org/10.1038/bjc.2013.645

WEN Y H , LIN H Q , LI H , et al. Stromal interleukin-33 promotes regulatory T cell-mediated immunosuppression in head and neck squamous cell carcinoma and correlates with poor prognosis [J ] . Cancer Immunol Immunother , 2019 , 68 ( 2 ): 221 - 232 . DOI: 10.1007/s00262-018-2265-2 http://doi.org/10.1007/s00262-018-2265-2

NIRSCHL C J , DRAKE C G . Molecular pathways: Coexpression of immune checkpoint molecules: signaling pathways and implications for cancer immunotherapy [J ] . Clin Cancer Res , 2013 , 19 ( 18 ): 4917 - 4924 . DOI: 10.1158/1078-0432.CCR-12-1972 http://doi.org/10.1158/1078-0432.CCR-12-1972

MRIZAK D , MARTIN N , BARJON C , et al. Effect of nasopharyngeal carcinoma-derived exosomes on human regulatory T cells [J ] . J Natl Cancer Inst , 2015 , 107 ( 1 ): 363 . DOI: 10.1093/jnci/dju363 http://doi.org/10.1093/jnci/dju363

GADWA J , BICKETT T E , DARRAGH L B , et al. Complement C3a and C5a receptor blockade modulates regulatory T cell conversion in head and neck cancer [J ] . J Immunother Cancer , 2021 , 9 ( 3 ): e002585 . DOI: 10.1136/jitc-2021-002585 http://doi.org/10.1136/jitc-2021-002585 https://jitc.bmj.com/lookup/doi/10.1136/jitc-2021-002585 https://jitc.bmj.com/lookup/doi/10.1136/jitc-2021-002585

ESCHWEILER S , RAMÍREZ-SUÁSTEGUI C , LI Y C , et al. Intermittent PI3Kδ inhibition sustains anti-tumour immunity and curbs irAEs [J ] . Nature , 2022 , 605 ( 7911 ): 741 - 746 . DOI: 10.1038/s41586-022-04685-2 http://doi.org/10.1038/s41586-022-04685-2

CHUCKRAN C A , CILLO A R , MOSKOVITZ J , et al. Prevalence of intratumoral regulatory T cells expressing neuropilin-1 is associated with poorer outcomes in patients with cancer [J ] . Sci Transl Med , 2021 , 13 ( 623 ): eabf8495 . DOI: 10.1126/scitranslmed.abf8495 http://doi.org/10.1126/scitranslmed.abf8495 https://www.science.org/doi/10.1126/scitranslmed.abf8495 https://www.science.org/doi/10.1126/scitranslmed.abf8495

RUTIHINDA C , HAROUN R , SAIDI N E , et al. Inhibition of the CCR6-CCL20 axis prevents regulatory T cell recruitment and sensitizes head and neck squamous cell carcinoma to radiation therapy [J ] . Cancer Immunol Immunother , 2023 , 72 ( 5 ): 1089 - 1102 . DOI: 10.1007/s00262-022-03313-2 http://doi.org/10.1007/s00262-022-03313-2

GONG L Q , LUO J , ZHANG Y , et al. Nasopharyngeal carcinoma cells promote regulatory T cell development and suppressive activity via CD70-CD27 interaction [J ] . Nat Commun , 2023 , 14 ( 1 ): 1912 . DOI: 10.1038/s41467-023-37614-6 http://doi.org/10.1038/s41467-023-37614-6

KESKINOV A A , SHURIN M R . Myeloid regulatory cells in tumor spreading and metastasis [J ] . Immunobiology , 2015 , 220 ( 2 ): 236 - 242 . DOI: 10.1016/j.imbio.2014.07.017 http://doi.org/10.1016/j.imbio.2014.07.017

BRONTE V , BRANDAU S , CHEN S H , et al. Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards [J ] . Nat Commun , 2016 , 7 : 12150 . DOI: 10.1038/ncomms12150 http://doi.org/10.1038/ncomms12150

VASQUEZ-DUNDDEL D , PAN F , ZENG Q , et al. STAT3 regulates arginase-Ⅰ in myeloid-derived suppressor cells from cancer patients [J ] . J Clin Invest , 2013 , 123 ( 4 ): 1580 - 1589 . DOI: 10.1172/JCI60083 http://doi.org/10.1172/JCI60083 http://www.jci.org/articles/view/60083 http://www.jci.org/articles/view/60083

GREENE S , ROBBINS Y , MYDLARZ W K , et al. Inhibition of MDSC trafficking with SX-682, a CXCR1/2 inhibitor, enhances NK-cell immunotherapy in head and neck cancer models [J ] . Clin Cancer Res , 2020 , 26 ( 6 ): 1420 - 1431 . DOI: 10.1158/1078-0432.CCR-19-2625 http://doi.org/10.1158/1078-0432.CCR-19-2625

ZHU G Q , YANG F , WEI H X , et al. 90 K increased delivery efficiency of extracellular vesicles through mediating internalization [J ] . J Control Release , 2023 , 353 : 930 - 942 . DOI: 10.1016/j.jconrel.2022.12.034 http://doi.org/10.1016/j.jconrel.2022.12.034 https://linkinghub.elsevier.com/retrieve/pii/S0168365922008483 https://linkinghub.elsevier.com/retrieve/pii/S0168365922008483

XU Y L , YAN J X , TAO Y , et al. Pituitary hormone α-MSH promotes tumor-induced myelopoiesis and immunosuppression [J ] . Science , 2022 , 377 ( 6610 ): 1085 - 1091 . DOI: 10.1126/science.abj2674 http://doi.org/10.1126/science.abj2674

PRASAD M , ZOREA J , JAGADEESHAN S , et al. MEK1/2 inhibition transiently alters the tumor immune microenvironment to enhance immunotherapy efficacy against head and neck cancer [J ] . J Immunother Cancer , 2022 , 10 ( 3 ): e003917 . DOI: 10.1136/jitc-2021-003917 http://doi.org/10.1136/jitc-2021-003917 https://jitc.bmj.com/lookup/doi/10.1136/jitc-2021-003917 https://jitc.bmj.com/lookup/doi/10.1136/jitc-2021-003917

GUAN L , NAMBIAR D K , CAO H B , et al. NFE2L2 mutations enhance radioresistance in head and neck cancer by modulating intratumoral myeloid cells [J ] . Cancer Res , 2023 , 83 ( 6 ): 861 - 874 .

VIVIER E , TOMASELLO E , BARATIN M , et al. Functions of natural killer cells [J ] . Nat Immunol , 2008 , 9 ( 5 ): 503 - 510 . DOI: 10.1038/ni1582 http://doi.org/10.1038/ni1582

MARTÍNEZ-LOSTAO L , ANEL A , PARDO J . How do cytotoxic lymphocytes kill cancer cells? [J ] . Clin Cancer Res , 2015 , 21 ( 22 ): 5047 - 5056 . DOI: 10.1158/1078-0432.CCR-15-0685 http://doi.org/10.1158/1078-0432.CCR-15-0685 https://aacrjournals.org/clincancerres/article/21/22/5047/79020/How-Do-Cytotoxic-Lymphocytes-Kill-Cancer-Cells https://aacrjournals.org/clincancerres/article/21/22/5047/79020/How-Do-Cytotoxic-Lymphocytes-Kill-Cancer-Cells

FREEMAN A J , VERVOORT S J , RAMSBOTTOM K M , et al. Natural killer cells suppress T cell-associated tumor immune evasion [J ] . Cell Rep , 2019 , 28 ( 11 ): 2784 - 2794 .e5. DOI: S2211-1247(19)31050-2 http://doi.org/S2211-1247(19)31050-2

VAN MONTFOORT N , BORST L , KORRER M J , et al. NKG2A blockade potentiates CD8 T cell immunity induced by cancer vaccines [J ] . Cell , 2018 , 175 ( 7 ): 1744 - 1755 .e15. DOI: 10.1016/j.cell.2018.10.028 http://doi.org/10.1016/j.cell.2018.10.028 https://linkinghub.elsevier.com/retrieve/pii/S0092867418313813 https://linkinghub.elsevier.com/retrieve/pii/S0092867418313813

LUDWIG S , FLOROS T , THEODORAKI M N , et al. Suppression of lymphocyte functions by plasma exosomes correlates with disease activity in patients with head and neck cancer [J ] . Clin Cancer Res , 2017 , 23 ( 16 ): 4843 - 4854 . DOI: 10.1158/1078-0432.CCR-16-2819 http://doi.org/10.1158/1078-0432.CCR-16-2819

SHEN X , WANG P , DAI P , et al. Correlation between human leukocyte antigen-G expression and clinical parameters in oral squamous cell carcinoma [J ] . Indian J Cancer , 2018 , 55 ( 4 ): 340 - 343 . DOI: 10.4103/ijc.IJC_602_17 http://doi.org/10.4103/ijc.IJC_602_17

ANDRÉ P , DENIS C , SOULAS C , et al. Anti-NKG2A MAb is a checkpoint inhibitor that promotes anti-tumor immunity by unleashing both T and NK cells [J ] . Cell , 2018 , 175 ( 7 ): 1731 - 1743 .e13. DOI: S0092-8674(18)31322-9 http://doi.org/S0092-8674(18)31322-9

RETICKER-FLYNN N E , ZHANG W R , BELK J A , et al. Lymph node colonization induces tumor-immune tolerance to promote distant metastasis [J ] . Cell , 2022 , 185 ( 11 ): 1924 - 1942 .e23. DOI: 10.1016/j.cell.2022.04.019 http://doi.org/10.1016/j.cell.2022.04.019 https://linkinghub.elsevier.com/retrieve/pii/S0092867422004664 https://linkinghub.elsevier.com/retrieve/pii/S0092867422004664

BERNAREGGI D , XIE Q , PRAGER B C , et al. CHMP2A regulates tumor sensitivity to natural killer cell-mediated cytotoxicity [J ] . Nat Commun , 2022 , 13 ( 1 ): 1899 . DOI: 10.1038/s41467-022-29469-0 http://doi.org/10.1038/s41467-022-29469-0

JUNG E K , CHU T H , VO M C , et al. Natural killer cells have a synergistic anti-tumor effect in combination with chemoradiotherapy against head and neck cancer [J ] . Cytotherapy , 2022 , 24 ( 9 ): 905 - 915 . DOI: 10.1016/j.jcyt.2022.05.004 http://doi.org/10.1016/j.jcyt.2022.05.004

LI X Y , CORVINO D , NOWLAN B , et al. NKG7 is required for optimal antitumor T-cell immunity [J ] . Cancer Immunol Res , 2022 , 10 ( 2 ): 154 - 161 . DOI: 10.1158/2326-6066.CIR-20-0649 http://doi.org/10.1158/2326-6066.CIR-20-0649 https://aacrjournals.org/cancerimmunolres/article/10/2/154/678010/NKG7-Is-Required-for-Optimal-Antitumor-T-cell https://aacrjournals.org/cancerimmunolres/article/10/2/154/678010/NKG7-Is-Required-for-Optimal-Antitumor-T-cell

CRIST M , YANIV B , PALACKDHARRY S , et al. Metformin increases natural killer cell functions in head and neck squamous cell carcinoma through CXCL1 inhibition [J ] . J Immunother Cancer , 2022 , 10 ( 11 ): e005632 . DOI: 10.1136/jitc-2022-005632 http://doi.org/10.1136/jitc-2022-005632 https://jitc.bmj.com/lookup/doi/10.1136/jitc-2022-005632 https://jitc.bmj.com/lookup/doi/10.1136/jitc-2022-005632

LEE Y M , CHEN Y H , OU D L , et al. SN-38, an active metabolite of irinotecan, enhances anti-PD-1 treatment efficacy in head and neck squamous cell carcinoma [J ] . J Pathol , 2023 , 259 ( 4 ): 428 - 440 . DOI: 10.1002/path.v259.4 http://doi.org/10.1002/path.v259.4 https://onlinelibrary.wiley.com/toc/10969896/259/4 https://onlinelibrary.wiley.com/toc/10969896/259/4

BOUTILIER A J , ELSAWA S F . Macrophage polarization states in the tumor microenvironment [J ] . Int J Mol Sci , 2021 , 22 ( 13 ): 6995 . DOI: 10.3390/ijms22136995 http://doi.org/10.3390/ijms22136995 https://www.mdpi.com/1422-0067/22/13/6995 https://www.mdpi.com/1422-0067/22/13/6995

WEI C , YANG C G , WANG S Y , et al. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis [J ] . Mol Cancer , 2019 , 18 ( 1 ): 64 . DOI: 10.1186/s12943-019-0976-4 http://doi.org/10.1186/s12943-019-0976-4

SHE L , QIN Y X , WANG J C , et al. Tumor-associated macrophages derived CCL18 promotes metastasis in squamous cell carcinoma of the head and neck [J ] . Cancer Cell Int , 2018 , 18 : 120 . DOI: 10.1186/s12935-018-0620-1 http://doi.org/10.1186/s12935-018-0620-1

GAO L , ZHANG W , ZHONG W Q , et al. Tumor associated macrophages induce epithelial to mesenchymal transition via the EGFR/ERK1/2 pathway in head and neck squamous cell carcinoma [J ] . Oncol Rep , 2018 , 40 ( 5 ): 2558 - 2572 . DOI: 10.3892/or.2018.6657 http://doi.org/10.3892/or.2018.6657

HU Y , HE M Y , ZHU L F , et al. Tumor-associated macrophages correlate with the clinicopathological features and poor outcomes via inducing epithelial to mesenchymal transition in oral squamous cell carcinoma [J ] . J Exp Clin Cancer Res , 2016 , 35 : 12 . DOI: 10.1186/s13046-015-0281-z http://doi.org/10.1186/s13046-015-0281-z http://jeccr.biomedcentral.com/articles/10.1186/s13046-015-0281-z http://jeccr.biomedcentral.com/articles/10.1186/s13046-015-0281-z

SUN H , MIAO C , LIU W , et al. TGF-β1/TβRⅡ/Smad3 signaling pathway promotes VEGF expression in oral squamous cell carcinoma tumor-associated macrophages [J ] . Biochem Biophys Res Commun , 2018 , 497 ( 2 ): 583 - 590 . DOI: 10.1016/j.bbrc.2018.02.104 http://doi.org/10.1016/j.bbrc.2018.02.104 https://linkinghub.elsevier.com/retrieve/pii/S0006291X18303334 https://linkinghub.elsevier.com/retrieve/pii/S0006291X18303334

HU Z W , WEN Y H , MA R Q , et al. Ferroptosis driver SOCS1 and suppressor FTH1 independently correlate with M1 and M2 macrophage infiltration in head and neck squamous cell carcinoma [J ] . Front Cell Dev Biol , 2021 , 9 : 727762 . DOI: 10.3389/fcell.2021.727762 http://doi.org/10.3389/fcell.2021.727762 https://www.frontiersin.org/articles/10.3389/fcell.2021.727762/full https://www.frontiersin.org/articles/10.3389/fcell.2021.727762/full

MOREIRA D , SAMPATH S , WON H , et al. Myeloid cell-targeted STAT3 inhibition sensitizes head and neck cancers to radiotherapy and T cell-mediated immunity [J ] . J Clin Invest , 2021 , 131 ( 2 ): 137001 .

浏览量

2071

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

MYC通过靶向CD47促进前列腺癌增殖和转移的机制研究

没食子酸增强CAR-T细胞抗实体瘤作用的研究

循环肿瘤细胞在胆管癌侵袭转移中的作用机制研究进展及展望

抗EGFR单抗联合免疫检查点抑制剂治疗头颈部鳞状细胞癌专家共识（2025年版）

生物3D打印在肿瘤研究及组织工程中的应用